2 husband, he brought her to the psychiatrist. A diagnosis of inhalant abuse was made, and patient was investigated with routine haematological and biochemical studies, liver/kidney function tests, B12 level, urine examination, radiographs of the chest, ECG, and brain CT imaging, which were normal. Mini international neuropsychiatric interview was insignif- icant for any other psychiatric disorder [1]. After psychoeducating regarding substance use and tak- ing support from the husband as cotherapist, she was initi- ated on weekly counseling and motivational enhancement therapy. Currently, after 8 weeks of regular sessions, the pa- tient is abstinent from the ﬂuid and reports euthymic mood with integration in her usual routine activities. 3. Discussion Inhalant abuse occurs throughout the world, in industri- alized nations as well as developing countries ravaging the society in innumerable ways [2]. Usually inhalant use onset is during childhood or adolescence with declining pattern but can continue into adulthood [2]. Use by adults may predom- inate under particular circumstances, such as when certain occupations make abusable solvents, propellants, or anes- thetics readily available. Data from the National Comorbidity Survey reveal that the aggregate prevalence of inhalant and other controlled substance abuse is as high as 7.5% in adults [3]. There is scarce data on inhalant use amongst adolescents and young adults from India [4]. This case highlights the importance of workplace, precipitating inhalant abuse onset in adult in lieu with stressful life circumstances. A sizable chunk of employees in the organized sector is substance users, while others (nonsubstance users) remain vulnerable to substance use [5]. Substance use inﬂuences work adversely in the form of inconsistent work quality, poor concentration, lowered productivity, increased absenteeism, errors in judgment, interpersonal diﬃculties, frequent ill- nesses, devastating accidents, and ﬁnancial losses [6]. Impor- tantly, these adverse consequences of substance use are not only limited to “dependent” users but are seen in occasional users as well [6]. Thus, “workplace” appears to be an appropriate setting for interventions to prevent inhalant abuse amongst other substance use among those at risk. As the world is moving towards increased industrialization, there is an urgent need to replicate and scale-up workplace-based interventions at a wider level including, but not limited to, substance use. We suggest that the awareness for harmful eﬀects of inhalant is required to be integrated within industrial health guidelines. Local manpower development for substance abuse cessation needs to be built to ensure continuation of assistance to the employees, and to encourage similar activities in nearby workplaces. 4. Conclusion With mounting stress in society, the availability of a sub- stance like inhalant needs to be addressed as certain char- acteristics of inhalants delineate it from other substances of Case Reports in Psychiatry abuse at workplace, important ones being easy procurement at workplace, unawareness about ill eﬀects, no signiﬁcant social awareness and restriction, no policy for inhalant abuse, and having similar pleasure eﬀects as other substances of abuse. Key Messages (1) Need to provide knowledge for harmful potential of inhalant use. (2) Concern to be raised about poor coping abilities with stressful life circumstances. (3) Need to targeting workplaces for avoiding potential inhalant abuse. (4) Focus on adult women as an emerging potential abuser. References [1] J. F. Williams, M. Storck, A. Joﬀe et al., “Inhalant abuse,” Pediatrics, vol. 119, no. 5, pp. 1009–1017, 2007. [2] J. C. Anthony, L. A. Warner, and R. C. Kessler, “Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic ﬁndings from the national comorbidity survey,” Experimental and Clinical Psychopharma- cology, vol. 2, no. 3, pp. 244–268, 1994. [3] S. Kumar, S. Grover, P. Kulhara et al., “Inhalant abuse: a clinic- based study,” Indian Journal of Psychiatry, vol. 50, pp. 117–120, 2008. [4] M. R. Frone, “Prevalence and distribution of illicit drug use in the workforce and in the workplace: ﬁndings and implications from a U.S. national survey,” Journal of Applied Psychology, vol. 91, no. 4, pp. 856–869, 2006. [5] J. Normand, R. O. Lempert, and C. P. O’Brien, Under the Inﬂu- ence? Drugs and the American Work Force, National Academy Press, Washington, DC, USA, 1994. [6] D. V. Sheehan, “The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10,” Journal of Clinical Psychiatry, vol. 59, pp. 22–23, 1998.